Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29535529 | 0.91 | POLB (0.36) | THRBHTTPOLBAPEX1TDP1 | |
| SCHEMBL15224723 | 0.80 | ALDH1A1 (0.38) | THRBHTTPOLBAPEX1TDP1 | |
| SCHEMBL13801023 | 0.79 | POLB (0.43) | THRBHTTPOLBAPEX1TDP1 | |
| SCHEMBL28552216 | 0.79 | POLB (0.44) | THRBHTTPOLBAPEX1TDP1 | |
| SCHEMBL27838486 | 0.77 | MAPT (0.46) | MAPTKMT2ACYP2C19HIF1ACHRM2 | |
| SCHEMBL7872447 | 0.76 | TDP1 (0.44) | THRBHTTPOLBAPEX1TDP1 | |
| SCHEMBL15188011 | 0.76 | CYP2C19 (0.41) | THRBHTTTDP1MAPTKMT2A | |
| Hydrochloric Acid SCHEMBL27613881 | 0.76 | POLB (0.40) | THRBHTTPOLBAPEX1TDP1 | |
| SCHEMBL8850852 | 0.74 | HIF1A (0.49) | THRBHTTPOLBAPEX1TDP1 | |
| SCHEMBL15168704 | 0.74 | CYP2C19 (0.39) | TDP1MAPTKMT2ACYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4022284-A1 | DETECTABLE ARRAYS FOR DISTINGUISHING ANALYTES AND DIAGNOSIS, AND METHODS AND SYSTEMS RELATED THERETO | Entopsis, Inc. (US) | 2022-07-06 | — | — | EP | claimed |
| WO-2021042063-A1 | DETECTABLE ARRAYS FOR DISTINGUISHING ANALYTES AND DIAGNOSIS, AND METHODS AND SYSTEMS RELATED THERETO | Entopsis, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| US-20200347380-A1 | Separation Device, and Method of Use, to Remove PCR Inhibitors from Whole Blood and Serum Samples | Entopsis, LLC (US) | 2020-11-05 | — | — | US | claimed |
| WO-2019113261-A1 | SEPARATION DEVICE, AND METHOD OF USE, TO REMOVE PCR INHIBITORS FROM WHOLE BLOOD AND SERUM SAMPLES | ENTOPSIS LLC (US) | 2019-06-13 | — | — | WO | claimed |
| US-7041747-B1 | Polymerizable compositions in non-flowable forms | HENKEL CORPORATION (US) | 2006-05-09 | — | — | US | claimed |
| WO-2000040663-A1 | ADHESION PROMOTERS | LOCTITE (R & D) LIMITED (IE) | 2000-07-13 | — | — | WO | claimed |
| EP-0130680-A2 | Cure to elastomers composition | LOCTITE CORPORATION (US) | 1985-01-09 | — | — | EP | claimed |
| US-4439600-A | Cure to elastomers compositions | LOCTITE CORPORATION (US) | 1984-03-27 | — | — | US | claimed |
| US-12600885-B2 | Composition including monomer with a carboxylic acid group, monomer with a hydroxyl group, an alkyl monomer, and crosslinker and related article and method | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-04-14 | — | — | US | disclosed |
| EP-4714984-A1 | DUAL CURE STRUCTURAL ADHESIVE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2026-03-25 | — | — | EP | disclosed |
| EP-4714985-A1 | DUAL CURE RESIN COMPOSITION | Henkel AG & Co. KGaA (DE) | 2026-03-25 | — | — | EP | disclosed |
| US-12448537-B2 | Curative free joint sealant | HENKEL AG & CO. KGAA (DE) | 2025-10-21 | — | — | US | disclosed |
| US-12378340-B2 | Crosslinkers and curable compositions including the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-08-05 | — | — | US | disclosed |
| EP-4588985-A1 | REACTIVE ADHESIVE TAPE | TESA SE (DE) | 2025-07-23 | — | — | EP | disclosed |
| US-5134175-A | Rapid curing high solids mixture of unsaturated prepolymers and monomers, photoinitiators, fillers, surfactants; for protective coatings, printing inks | MLT/MICRO-LITE TECHNOLOGY CORPORATION | 1992-07-28 | — | — | US | disclosed |
| EP-0114117-B1 | RAPID CURE ACRYLIC MONOMER SYSTEMS | LOCTITE CORPORATION (US) | 1986-09-24 | — | — | EP | disclosed |
| US-4574138-A | FREE RADICAL CATALYST, URETHANE ACRYLATE | LOCTITE CORPORATION A CT CORP | 1986-03-04 | — | — | US | disclosed |
| EP-0130680-A2 | Cure to elastomers composition | LOCTITE CORPORATION (US) | 1985-01-09 | — | — | EP | disclosed |
| EP-0114117-A1 | Rapid cure acrylic monomer systems | LOCTITE CORPORATION (US) | 1984-07-25 | — | — | EP | disclosed |
| US-4439600-A | Cure to elastomers compositions | LOCTITE CORPORATION (US) | 1984-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600885-B2 | Composition including monomer with a carboxylic acid group, monomer with a hydroxyl group, an alkyl monomer, and crosslinker and related article and method | RAD51, HACL2, COL2A1 | THRB 3014/4885HTT 3546/4885POLB 1960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.